The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s orthopedic regenerative surgical products market report forecasts the orthopedic regenerative surgical products market size to grow to $5.38 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Orthopedic Regenerative Surgical Products Market Report 2023 – https://www.thebusinessresearchcompany.com/report/orthopedic-regenerative-surgical-products-global-market-report

Orthopedic Regenerative Surgical Products Market Size Forecast
The global orthopedic regenerative surgical products market is expected to grow from $3.89 billion in 2022 to $4.2 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orthopedic regenerative surgical products market size is expected to grow to $5.38 billion in 2027 at a CAGR of 6.4%.

North America held the largest orthopedic regenerative surgical products market share and was the fastest-growing region in 2022.

Key Orthopedic Regenerative Surgical Products Market Driver ­– Rise In The Prevalence Of Orthopedic Diseases Across The Globe
Approximately 1.71 billion people have musculoskeletal conditions worldwide. The orthopedic disease musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries. Hence, the rising prevalence of orthopedic diseases drives the market for orthopedic regenerative surgical products.

Request for A Sample Of The Global Orthopedic Regenerative Surgical Products Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6764&type=smp

Key Orthopedic Regenerative Surgical Products Market Trend – Technological Advancement
For instance, in 2021, the USA-based Anika Therapeutics, Inc., a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, announced the successful completion of the first human surgical procedure with its injectable HA-based bone repair therapy for the treatment of bone voids and other skeletal system bone defects caused by trauma or age-related degeneration. Around 900,000 people require treatment for bone voids and other bone defects of the knee, which cause pain and impaired function and may necessitate total joint replacement therapy.

Orthopedic Regenerative Surgical Products Market Segment
1) By Product: Allograft, Synthetic, Cell-based, Viscosupplements
2) By Application: Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users

Orthopedic Regenerative Surgical Products Market Major Players and Strategies
Major players in the orthopedic regenerative surgical products market are Baxter, Zimmer Biomet, Stryker, Smith&Nephew, Allosource, Amniox Medical Inc., Anika Therapeutics Inc., Vericel Corporation, Vsy Biotechnology GmbH, Aptissen S.A., Mimedx, and TissueTech Inc.

In 2021, Stryker, a US-based multinational medical technologies corporation, acquired OrthoSensor Inc for an undisclosed amount. This acquisition aimed to develop the medical & surgical, neurotechnology and spine that help improve patient and hospital outcomes. OrthoSensor Inc is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. OrthoSensor’s headquarters is in Dania Beach, USA.

The Orthopedic Regenerative Surgical Products Global Market Report 2023 covers regional data on orthopedic regenerative surgical products market size, orthopedic regenerative surgical products market trends and drivers, opportunities, strategies, and orthopedic regenerative surgical products market competitor analysis. The countries covered in the orthopedic regenerative surgical products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Orthopedic regenerative surgical products are used for the treatment of joint pains, gout, articular defects, fibromyalgia, and osteoarthritis, as well as trauma and joint replacement, joint problems, regenerative orthopedic medicine using platelet-rich plasma (PRP) which is frequently the nonsurgical treatment of choice to assist patients in healing and repairing many musculoskeletal (orthopedic) injuries such as joint, tendon, ligament, and muscular injuries. The orthopedic regenerative surgical products are curing many other musculoskeletal injuries.

View More Reports Related To The Orthopedic Regenerative Surgical Products Market –
Handheld Surgical Devices And Equipment Global Market Report 2023
Spinal Surgery Devices And Equipment Global Market Report 2023
ENT Surgical Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: